Home
>
US Stocks
>
RAPT Therapeutics Inc
RAPT Therapeutics Inc
RAPT

RAPT Therapeutics Inc (RAPT)

$32.760.15%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$31.76
Today Low/High$31.76 / $33.3
52 Week Low/High$14.63 / $43.26
Market Cap$958.37M

Company Details

RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary discovery and development engine, the Company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. RAPT has discovered and advanced two unique drug candidates, FLX475 and RPT193, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of cancer and inflammation, respectively. The Company is also pursuing a range of targets that are in the discovery stage of development.
OrganisationRAPT Therapeutics Inc
HeadquatersSouth San Francisco, California, US
Employees68
IndustryHealth Technology
CEOBrian Wong

Discover more

Frequently Asked Questions

What is RAPT Therapeutics Inc (RAPT) share price today?

Can Indians buy RAPT Therapeutics Inc (RAPT) shares?

How can I buy RAPT Therapeutics Inc (RAPT) shares from India?

Can Fractional shares of RAPT Therapeutics Inc (RAPT) be purchased?

What are the documents required to start investing in RAPT Therapeutics Inc (RAPT) stocks?

We are a SEBI registered investement advisor